4.6 Article

Excess morbidity and mortality among survivors of childhood acute lymphoblastic leukaemia: 25 years of follow-up from the United Kingdom Childhood Cancer Study (UKCCS) population-based matched cohort

Related references

Note: Only part of the references are listed.
Article Oncology

Risk of cerebrovascular disease among 13 457 five-year survivors of childhood cancer: A population-based cohort study

Raoul C. Reulen et al.

Summary: Childhood cancer survivors treated with cranial irradiation are at increased risk of cerebrovascular disease, with survivors of central nervous system tumors and leukemia at the greatest risk. The risk of CVD continues to rise substantially beyond age 50, highlighting the need for ongoing monitoring and lifestyle interventions in this population.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Hematology

Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia

David T. Teachey et al.

Summary: The majority of children and young adults with acute lymphoblastic leukemia (ALL) are cured with contemporary multiagent chemotherapy regimens, which include cycles of chemotherapy over 2-3 years with CNS prophylaxis.

BLOOD (2021)

Article Oncology

A vulnerable age group: the impact of cancer on the psychosocial well-being of young adult childhood cancer survivors

L. M. E. van Erp et al.

Summary: The study found that YACCS are vulnerable to psychosocial difficulties but also experience positive long-term impacts of childhood cancer. Positive and negative impacts of childhood cancer were associated with psychosocial outcomes in YACCS. Screening of psychosocial outcomes and offering targeted interventions are necessary to optimize psychosocial long-term follow-up care for YACCS.

SUPPORTIVE CARE IN CANCER (2021)

Article Medicine, General & Internal

National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol

Liv Andres-Jensen et al.

Summary: This study aims to establish a Nordic, national childhood ALL survivor cohort to investigate the somatic and psychosocial treatment-related burden and associated risk factors. Primary endpoints include the cumulative incidence and burden of 197 health conditions, while secondary endpoints focus on organ-specific outcomes and psychosocial outcomes.

BMJ OPEN (2021)

Article Medicine, General & Internal

Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort

Maxine J. E. Lamb et al.

Summary: The study found that patients with MGUS had excess morbidity in the 5 years before diagnosis and excess mortality and morbidity in the 3 years after diagnosis. In contrast, only marginal increases in mortality and morbidity were evident for patients with MBL.

BMJ OPEN (2021)

Article Medicine, General & Internal

Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort study

Karen Schow Jensen et al.

Summary: Survivors of childhood ALL showed significantly higher health care utilization across primary and secondary sectors compared to the reference population, with a decreasing trend over 15 years in post-treatment healthcare needs.

BMJ OPEN (2021)

Review Medicine, General & Internal

Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia

Hiroto Inaba et al.

Summary: Over the past five decades, the outcomes of pediatric acute lymphoblastic leukemia (ALL) have significantly improved, with 5-year survival rates exceeding 90% in high-income countries. The goal for the next decade is to further increase survival towards 100% and minimize treatment-related adverse effects. Genome-wide analyses have allowed for the classification of ALL into various subtypes, with treatment response and minimal residual disease analysis providing insights for new therapeutic strategies.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Oncology

Pediatric Acute Lymphoblastic Leukemia, Version 2.2020

Patrick Brown et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Review Oncology

Current and coming challenges in the management of the survivorship population

Eric J. Chow et al.

SEMINARS IN ONCOLOGY (2020)

Article Oncology

Long-Term Risk of Hospitalization Among Five-Year Survivors of Childhood Leukemia in the Nordic Countries

Gitte Vrelits Sorensen et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Review Oncology

Surveillance for Late Effects in Childhood Cancer Survivors

Wendy Landier et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Oncology

Hospitalization and mortality among pediatric cancer survivors: a population-based study

Beth A. Mueller et al.

CANCER CAUSES & CONTROL (2018)

Editorial Material Oncology

Converting Epidemiologic Studies of Cancer Etiology to Survivorship Studies: Approaches and Challenges

Amy Berrington de Gonzalez et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)

Article Medicine, General & Internal

Long-term Risks of Subsequent Primary Neoplasms Among Survivors of Childhood Cancer

Raoul C. Reulen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Oncology

Childhood cancer survival: A report from the United Kingdom Childhood Cancer Study

W. Thomas Johnston et al.

CANCER EPIDEMIOLOGY (2010)

Article Public, Environmental & Occupational Health

Childhood leukaemia and socioeconomic status: fact or artefact? A report from the United Kingdom childhood cancer study (UKCCS)

Alex Smith et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)

Article Hematology

Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999

JM Chessells et al.

BRITISH JOURNAL OF HAEMATOLOGY (2002)